The global nanorobotics market reached a value of US$ 5.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.0 Billion by 2027, exhibiting a CAGR of 11.75% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Nanorobotics refers to an emerging technology that helps to create machines or robots that have components around the scale of a nanometer. These robots are known as nanorobots and can be injected into patients for performing diagnosis or providing treatment at the cellular level. They can also be used in pharmacokinetics, disease monitoring, targeting drug delivery in cancer therapeutics and improving the effectiveness and efficiency of healthcare. Besides this, they are utilized for assembling and maintaining sophisticated systems.

Extensive applications of nanorobotics in the medical industry are one of the primary factors driving the market growth. Recent research has suggested that nanorobots can serve as antibodies or antiviral agents in patients with compromised immunity or diseases that do not respond to conventional treatment methods. As a result, nanorobots are being used in gene therapy and cancer detection and treatment. They are also being employed in various dentistry procedures and act as ancillary devices for processing different chemical reactions in the affected organs. Furthermore, nanorobots are utilized for monitoring and controlling glucose levels in diabetic patients. Some of the other medical applications of nanorobots that are strengthening the nanorobotics market growth include repairing damaged tissues and unblocking arteries affected by plaques. Apart from this, governments of several countries are extending their support by increasing investments in nanorobotics. Consequently, the leading players are increasing their focus on research and development (R&D) activities to introduce technological advancements in molecular robotics.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global nanorobotics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type and application.

Breakup by Type:

3D-Motion Nanomachines
Bacteria Powered Nanobots
Biochips
Nubots
Nanorockets
Others

Breakup by Application:

Medical Imaging
Information Storage
Drug Delivery
Health Sensors and Replicators
Others

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Bruker Corporation, EV Group, Ginkgo Bioworks Inc., Imina Technologies SA, JEOL Ltd., Kleindiek Nanotechnik GmbH, Nanonics Imaging Limited, Oxford Instruments plc, Synthace Limited, Thermo Fisher Scientific Inc., Toronto Nano Instrumentation Inc. and Zymergen Inc.

Key questions answered in this report:
How has the global nanorobotics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global nanorobotics market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global nanorobotics market and who are the key players?
What is the degree of competition in the industry?